Impact of current smoking on the clinical course of microscopic colitis

Inflammatory Bowel Diseases

Volumn 19, Issue 7, 2013, Pages 1470-1476

  Fernández Bañares, Fernando ^a,b   De Sousa, Monia R ^c   Salas, Antonio ^a,b   Beltrán, Belén ^b,d   Piqueras, Marta ^e   Iglesias, Eva ^f   Gisbert, Javier P ^b,g   Lobo, Beatriz ^b,h   Puig Diví, Valentí ^b,i   García Planella, Esther ^j   Ordás, Ingrid ^b,k   Andreu, Montserrat ^l   Calvo, Marta ^m   Montoro, Miguel ^c   Esteve, Maria ^a,b   Viver, Josep M ^a,b  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL SAN JORGE   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e Hospital La Fe ^*  (Spain)

^f HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL DE SABADELL   (Spain)

^j Hospital Sant Pau   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l HOSPITAL DEL MAR   (Spain)

^m HOSPITAL INFANTA CRISTINA   (Spain)

more..

Author keywords

Clinical areas; Collagenous colitis; Environmental risk factors; Lymphocytic colitis; Smoking nicotine in IBD

Indexed keywords

ADULT; ARTICLE; COLLAGENOUS COLITIS; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LYMPHOCYTIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC COLITIS; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SMOKING; SMOKING HABIT; TREATMENT RESPONSE;

AGED; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, MICROSCOPIC; COLONOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SMOKING;

EID: 84879089778     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318281f3cc     Document Type: Article

References (28)

1. Jawahari A, Talbot JC. Microscopic and collagenous colitis. Histopathology. 1996;29:101-110.
2. Münch A, Aust D, Bohr J, et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis. 2012;6:932-945.
3. Fernández-Bañares F, Salas A, Esteve M, et al. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a populationbased study. Inflamm Bowel Dis. 2011;17:1015-1020.
4. Pardi DS, Kelly CP. Microscopic colitis. Gastroenterology. 2011;140:1155-1165.
5. Fernández-Bañares F, De Sousa MR, Salas A, et al; for the RECOMINA Project, GETECCU (Grupo Español de Enfermedades de Crohn y Colitis Ulcerosa). Epidemiological risk factors in microscopic colitis: a prospective case-control study. Inflamm Bowel Dis. 2013;19:411-417.
6. Vigren L, Sjoberg K, Benoni C, et al. Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol. 2011;46:1334-1339.
7. Nyhlin N, Montgomery SM, Wickbom A, et al. Symptom burden in collagenous and lymphocytic colitis compared to a matched control group. Gut. 2009;58(Suppl 2):A309.
8. Yen EF, Pokhrel B, Du H, et al. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis. 2012;18:1835-1841.
9. Nunes T, Etchevers MJ, Merino O, et al; for the TABACROHN Study Group of GETECCU, Spanish Working Group in Crohn's Disease and Ulcerative Colitis. Does smoking influence Crohn's disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis. 2012..
10. Cosnes J, Carbonnel F, Beaugerie L, et al. Effects of smoking on the long term course of Crohn's disease. Gastroenterology. 1996;110:424-431.
11. Tysk C, Bohr J, Nyhlin N, et al. Diagnosis and management of microscopic colitis. World J Gastroenterol. 2008;14:7280-7288.
12. Salas A, Fernández-Bañares F, Casalots J, et al. Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology. 2003;43:48-54.
13. El-Tawil AM. Smoking and inflammatory bowel diseases: what in smoking alters the course? Int J Colorectal Dis. 2010;25:671-680.
14. Srivastava ED, Russell M A H, Feyerabend C, et al. Effect of ulcerative colitis and smoking on rectal blood flow. Gut. 1990;31:1021-1024.
15. Thomas G A O, Rhodes J, Ingram JR. Mechanisms of disease: nicotine - a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:536-544.
16. Hatoum OA, Heidemann J, Binion DG. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Ann N Y Acad Sci. 2006;1072:78-97.
17. Griga T, Tromm A, Schmiegel W, et al. Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms. Eur J Gastroenterol Hepatol. 2004;16:397-402.
18. Taha Y, Raab Y, Larsson A, et al. Vascular endothelial growth factor (VEGF)-a possible mediator of inflammation and mucosal permeability in patients with collagenous colitis. Dig Dis Sci. 2004;49:109-115.
19. Kikuchi H, Itoh J, Fukuda S. Chronic nicotine stimulation modulates the immune response of mucosal T cells to Th1-dominant pattern via nAChR by upregulation of Th1-specific transcriptional factor. Neurosci Lett. 2008;432:217-221.
20. Tagkalidis PP, Gibson PR, Bhathal PS. Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol. 2007;60:382-387.
21. Kumawat A, Strid H, Elgbratt K, et al. Collagenous colitis patients demonstrate a Th1/CTL-associated gene expression profile with increased frequencies of Ki67+ proliferating and CD45RO+ activated/memory CD8+ and CD8+CD4+ mucosal T cells. Gurt. 2011;60(Suppl 3):A318.
22. Münch A, Söderholm JD, Ost A, et al. Increased transmucosal uptake of E. coli K12 in collagenous colitis persists after budesonide treatment. Am J Gastroenterol. 2009;104:679-685.
23. Feyen B, Wall GC, Finnerty EP, et al. Meta-analysis: budesonide treatment for collagenous colitis. Aliment Pharmacol Ther. 2004;20:745-749.
24. Fernandez-Bañares F, Salas A, Esteve M, et al. Collagenous and lymphocytic colitis. Evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol. 2003;98:340-347.
25. Calabrese C, Gionchetti P, Liguori G, et al. Clinical course of microscopic colitis in a single-center cohort study. J Crohns Colitis. 2011;5:218-221.
26. Sveinsson OA, Orvar KB, Birgisson S, et al. Clinical features of microscopic colitis in a nation-wide follow-up study in Iceland. Scand J Gastroenterol. 2008;43:955-960.
27. Miehlke S, Madisch A, Voss C, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther. 2005;22:1115-1119.
28. Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut. 2003;52:248-251.